GB191414972A - An Improved Process for Producing Sera and Vaccines. - Google Patents

An Improved Process for Producing Sera and Vaccines.

Info

Publication number
GB191414972A
GB191414972A GB191414972DA GB191414972A GB 191414972 A GB191414972 A GB 191414972A GB 191414972D A GB191414972D A GB 191414972DA GB 191414972 A GB191414972 A GB 191414972A
Authority
GB
United Kingdom
Prior art keywords
bacteria
rays
toxines
vaccines
subjected
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
Inventor
Otto Stiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of GB191414972A publication Critical patent/GB191414972A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0028—Disruption, e.g. by heat or ultrasounds, sonophysical or sonochemical activation, e.g. thermosensitive or heat-sensitive liposomes, disruption of calculi with a medicinal preparation and ultrasounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/10—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person
    • A61K41/17—Inactivation or decontamination of a medicinal preparation prior to administration to an animal or a person by ultraviolet [UV] or infrared [IR] light, X-rays or gamma rays

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

14,972. Stiner, O. June 21, 1913, [Convention date]. Anti-toxines, toxines, vaccines, and immunizing serums.-Relates to the production of sera, vaccines &c. by the type of process in which bacteria or their products are subjected to the action of ultra-violet rays, and consists in subjecting bacteria to the rays for a prolonged period so that the bacteria are completely opened up or disintegrated. Tubercle bacilli suspended in a solution of common salt may be treated by means of a mercury quartz lamp such as that described in Specification 7669/10. In another example, tubercle bacilli in Koch's tuberculin are subjected to the rays so as to yield a portion of their substance to the suspension fluid which is then injected into an animal for the production of a serum, or subjected to further treatment by the rays so as to be rendered partly non-poisonous and suitable for direct injection for therapeutic purposes. Diphtheria baccili may be treated in a corresponding manner. The Specification, as open to inspection under Section 91 (3) (a), comprises also the treatment of bacteria toxines, endotoxines, serums, and other. bacterial products for varying periods to reduce their virulence or to eliminate certain constituents. This subject-matter does not appear in the Specification as accepted.
GB191414972D 1913-06-21 1914-06-23 An Improved Process for Producing Sera and Vaccines. Expired GB191414972A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT191414972X 1913-06-21

Publications (1)

Publication Number Publication Date
GB191414972A true GB191414972A (en) 1916-06-22

Family

ID=32513212

Family Applications (1)

Application Number Title Priority Date Filing Date
GB191414972D Expired GB191414972A (en) 1913-06-21 1914-06-23 An Improved Process for Producing Sera and Vaccines.

Country Status (1)

Country Link
GB (1) GB191414972A (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554242A (en) * 1946-01-26 1951-05-22 Nat Jewish Hospital Process for preparing pure autolytic tuberculin
US3019168A (en) * 1956-02-20 1962-01-30 Parke Davis & Co Heat and ultra-violet light attenuation of polio virus
EP0146144A2 (en) * 1983-12-19 1985-06-26 Freiherr von Malsen-Ponickau, Egbert Vaccine and process for its preparation

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2554242A (en) * 1946-01-26 1951-05-22 Nat Jewish Hospital Process for preparing pure autolytic tuberculin
US3019168A (en) * 1956-02-20 1962-01-30 Parke Davis & Co Heat and ultra-violet light attenuation of polio virus
EP0146144A2 (en) * 1983-12-19 1985-06-26 Freiherr von Malsen-Ponickau, Egbert Vaccine and process for its preparation
WO1985002771A1 (en) * 1983-12-19 1985-07-04 Freiherr Von Malsen Ponickau E Inoculum and production process
EP0146144A3 (en) * 1983-12-19 1985-07-24 Malsen Ponickau Egbert Frh Von Vaccine and process for its preparation

Similar Documents

Publication Publication Date Title
GB1088304A (en) Method of producing a pure, highly viscous hyaluronic acid preparation
ATE330002T1 (en) METHOD FOR PRODUCING MEMBRANE VESICLES
DE3806565A1 (en) VIRUS-MODIFIED TUMOR VACCINES FOR THE IMMUNOTHERAPY OF TUMOR METAL KEYS
JPS58167517A (en) Bacteria toxoid and gram-negative immunogloblin
Pope et al. The preparation of diphtheria antitoxin in a state of high purity
US3227626A (en) Plasminogen heat sterilization
GB191414972A (en) An Improved Process for Producing Sera and Vaccines.
EP0513225A1 (en) Enzyme treated bcg vaccine and process therefor
US20040009195A1 (en) Modified sialic acid vaccines
Stavitsky Antibody Synthesis by Homotransplanted Cells and Tissues: I. Study of Factors Which Influence the Process in the Rabbit
US2373454A (en) Method of preparing tetanus toxin
US2151364A (en) Anthrax vaccine
US2965543A (en) Alcohol detoxification of pertussis vaccines
Prensky et al. ARE MYELIN PROTEINS SYNTHESIZED IN RETINAL GANGLION CELLS? 1
US3208909A (en) Anaerobic process for production of a gel-adsorbed anthrax immunizing antigen
Romerdahl et al. Regulation of the immune response against UV-induced skin cancers: specificity of helper cells and their susceptibility to UV-induced suppressor cells.
US3968202A (en) Tetanus antigen and process for its manufacture
Shah et al. Vacuolating cytotoxic activity of Pasteurella multocida causing haemorrhagic septicaemia in buffalo and cattle
US2057623A (en) Antitoxin
US2224591A (en) Antigenic substance
Wago Antibody Production in Rabbits Following Injection with Pancreatic Ferments
Silverman et al. Production of protective antigens by Pasteurella pestis in a synthetic medium
US1547369A (en) Scarlet-fever toxin and antitoxin and process for producing the same
Ambrosch et al. Determination of meningococcal antibodies by microassay
Fischer Action of antigen on fibroblasts in vitro